Competition in the drug industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981.

Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)

Frecuentes preguntas acerca de las drogas genéricas.
Published: (2004)

Administered Prices. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on May 10-13, 1960.
Published: (1960)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Generic drugs : saving money at the pharmacy.
Published: (1998)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Generic drugs : saving money at the pharmacy /
Published: (1998)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)

Generic substitution and prescription drug prices : economic effects of state drug product selection laws /
by: Masson, Alison, et al.
Published: (1985)

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003.
Published: (2003)

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003.
Published: (2003)

Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994.
Published: (1995)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Published: (2002)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006.
Published: (2006)

Quick tips, when getting a prescription.
Published: (2002)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006.
Published: (2006)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Generic Animal Drug and Patent Term Restoration Act : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, second session on H.R. 4982 ... September 14, 1988.
Published: (1989)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007.
Published: (2008)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Increasing generic drug use : savings for seniors and Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, September 21, 2006.
Published: (2007)

Increasing generic drug use : savings for seniors and Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, September 21, 2006.
Published: (2007)